3
Clinical Trials associated with Umbilical Cord Mesenchymal Stem Cell(University of Indonesia)Investigation of safety and efficacy of intrathecal and intravenous injection of umbilical cord-derived mesenchymal stem cells (UC-MSC) in patients with multiple sclerosis
The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial
The objective of this study is to observe the potency of umbilical cord-derived mesenchymal stem cells (UC-MSC) and umbilical cord-derived conditioned medium (UC-CM), or triamcinolone acetonide (TA) in keloid therapy, measured by the decrease in the type 1:3 collagen ratio and the increase of IL-10 levels carried out using CONSORT statement.
Umbilical cord mesenchymal stem cells for the treatment of patients at high risk of novel coronavirus pneumonia (COVID-19): a single-center, prospective, open clinical study
Start Date20 Feb 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with Umbilical Cord Mesenchymal Stem Cell(University of Indonesia)
100 Translational Medicine associated with Umbilical Cord Mesenchymal Stem Cell(University of Indonesia)
100 Patents (Medical) associated with Umbilical Cord Mesenchymal Stem Cell(University of Indonesia)
100 Deals associated with Umbilical Cord Mesenchymal Stem Cell(University of Indonesia)